-
Rapastinel (INNTooltip
International Nonproprietary Name) (former
developmental code name GLYX-13) is a
novel antidepressant that was
under development...
- in
vitro and is
intended as an improved, follow-up drug to
rapastinel.
Similar to
rapastinel,
apimostinel is an
amidated tetrapeptide, but has been structurally...
- plasticity. Its
mechanism of
action is
similar to that of
rapastinel. However,
unlike rapastinel,
zelquistinel is
orally bioavailable,
exhibits increased...
-
Other partial agonists of the NMDA
receptor acting on
novel sites such as
rapastinel (GLYX-13) and
apimostinel (NRX-1074) are now
viewed for the development...
- HA-966 L-687414 L-Alanine L-Serine
Milacemide Neboglamine (nebostinel)
Rapastinel (GLYX-13) Sarcosine;
Polyamine site agonists:
Neomycin Spermidine Spermine;...
- HA-966 L-687414 L-Alanine L-Serine
Milacemide Neboglamine (nebostinel)
Rapastinel (GLYX-13) Sarcosine;
Polyamine site agonists:
Neomycin Spermidine Spermine;...
- HA-966 L-687414 L-Alanine L-Serine
Milacemide Neboglamine (nebostinel)
Rapastinel (GLYX-13) Sarcosine;
Polyamine site agonists:
Neomycin Spermidine Spermine;...
- HA-966 L-687414 L-Alanine L-Serine
Milacemide Neboglamine (nebostinel)
Rapastinel (GLYX-13) Sarcosine;
Polyamine site agonists:
Neomycin Spermidine Spermine;...
- NMDA
receptor antagonists,
including memantine, lanicemine, rislenemdaz,
rapastinel, and 4-chlorokynurenine, have thus far
failed to
demonstrate significant...
- HA-966 L-687414 L-Alanine L-Serine
Milacemide Neboglamine (nebostinel)
Rapastinel (GLYX-13) Sarcosine;
Polyamine site agonists:
Neomycin Spermidine Spermine;...
